Monday, August 6, 2007

Credit Crunch May Freeze M&A

The global credit squeeze that has shaken debt and equity markets during the past few weeks may cool the feverish pace of industry M&A. Banks are left holding debt of about $400 billion in uncompleted management and leveraged buyouts worldwide, according to estimates compiled by Baring Asset Management (London). Several big chemical deals are in that pipeline, including Sabic-GE Plastics, Basell-Lyondell, Hexion-Huntsman, and Carlyle-PQ Corp. Industry deals with committed financing are likely to proceed, say M&A advisers that CW contacted earlier this month. However, the relationship between buyers and their lenders could become tense if banks are stuck with debt they cannot sell on the bond market. That will curtail further lending until banks are able to clear the backlog. Most bankers expect a recovery by early 2008, citing an overall strong economy. “This is a different situation than what has happened in the past,” says Richard Whitney, managing director/chemicals at Credit Suisse (New York). Lenders have clamped down despite low default rates and relatively strong earnings and valuations, Whitney says. “Credit supply and demand is out of balance right now. It is not just in chemicals. It is on a global scale. There are so many large transactions that need financing.” Borrowing costs will rise as lenders demand higher risk premiums, analysts say.
“We think this is more of a correction or pause,” says Ron Kahn, head of the debt private placements group at Lincoln International (Chicago). “If you go back to the last serious credit crunch, back in 2001, it was driven by defaults and bad credits.” But the drivers are different now as defaults are low and earnings strong. “This has nothing to do with the fundamentals. It’s purely a liquidity issue,” Kahn says. Deals already in process are progressing, says Chris Cerimele, senior v.p. at Lincoln International. However, sale processes that were planned or just starting are likely to be delayed until after Labor Day, as buyers and sellers wait for the situation to stabilize. Banks are likely to tighten lending terms going forward, analysts say.
“M&A could be a tale of two cities for each half of the year in 2007,” says Peter Young, president of Young & Partners (New York), an M&A advisory firm. “There are enough announced and completed first-half deals so that 2007 will still be a pretty active year. The second half is going to be tough, however.

Friday, August 3, 2007

Rohm and Haas Loses Taste for Salt

Rohm and Haas (R&H) says it is considering “strategic options” for its salt business, which could include a divestment or spin-off. The company says it expects to make a decision by year-end. R&H’s salt business posted sales of $505 million in first-half 2007, an increase of 19% from the prior-year period. Earnings for the six-month period were $37 million, an increase of 85%, in line with improved sales performance, and offsetting higher operating costs, R&H says. Revenue increased on stronger pricing in the industrial and consumer markets, as well as increased demand for ice-control salt and other bulk products, R&H says. R&H’s salt business accounts for roughly 10% of its revenues and includes the Morton Salt name and trademark, including the image of the Morton Salt umbrella girl, a well-recognized consumer product symbol in North America. Also, R&H will no longer seek to maintain credit ratios consistent with an “A” rating, according to quarterly regulatory filings made late last month. “Rather, we intend to manage our debt levels in a manner consistent with maintaining investment-grade quality ratios,” R&H says in the filings. The company expects to maintain a debt ratio of 50% over the next several years, up from 35% at the end of the second quarter. R&H says it will use cash to: reinvest in core businesses; build new platforms to address growing needs in health, water, energy, and other areas; make selective acquisitions that add new technology or broaden geographic presence; continue to increase dividends; and to repurchase shares. R&H announced plans last month to repurchase up to $2 billion of its common stock, including $1 billion in shares through an accelerated buyback program this quarter that will be funded by the issuance of new debt.

Friday, July 20, 2007

Summer Pickup Game

So much for the dog days of summer. This is turning out to be an extraordinary season for the industry. Three deals have eclipsed the $10-billion mark so far, and there have been a scattering of billion-dollar transactions. Sabic, Apollo Management (New York), and Access Industries (New York)—industry’s emerging heavy hitters—have recently agreed to acquire GE Plastics, Huntsman, and Lyondell, respectively, in separate deals valued at more than $10 billion each. Akzo Nobel soon could join that once-exclusive club, if it decides to press ahead with a formal bid for ICI.
Could Sabic, Apollo, Access and perhaps others have designs on creating a chemical industry Champions League this summer, with plans to keep acquiring available industry assets until no one is left on the sidelines? More seriously, one wonders what will bring an end to this activity. Will activity moderate, or will there be some industry or macro mega-event—along the lines of a default that further spooks the bond markets, or something like the late-1990s Asian currency crisis—that shuts down activity.

Thursday, July 19, 2007

Three Abiquim Officials Killed in Brazil Plane Crash

Three officials of Abiquim (São Paulo), the Brazilian chemical industry association, were among those killed in yesterday’s crash of a TAM Airlines flight in São Paulo, according to a post on Abiquim’s Web site (www.abiquim.org.br). “The members of Abiquim’s board of directors, and Abiquim officials, regret to inform that Abiquim’s executive vice president Guilherme Duque Estrada de Moraes, adjunct director for regulatory affairs Marta Maria Franco Laudares de Almeida, and the technical adviser Mirtes Suda were victims of the tragedy of TAM flight JJ 3054, on the evening of July 17,” according to a statement on Abiquim’s Web site. Abiquim offered its “deepest condolences to the families of Abiquim’s representatives and to all of the victims of the tragedy.” The flight was arriving in São Paulo from Porto Alegre, Brazil when the crash occurred.

Tuesday, July 17, 2007

Private Equity Takes Stake

Two recent deals demonstrate how private equity continues to reshape the industry’s landscape by assembling and building leading industry franchises. CVC Capital Partners’ (London) agreement to acquire Univar for about €1.52 billion ($2.1 billion) would further increase the number of top chemical distributors under private ownership (p. 6). Apollo Management’s (New York) agreement, through its Hexion Specialty Chemicals subsidiary, to acquire Huntsman for $10.6 billion, would create a $14-billion/year global differentiated and specialty chemical giant. A sale or merger of Huntsman was inevitable because the controlling shareholders were seeking to sell. Founder and chairman Jon Huntsman had publicly stated his intent to sell his stake in the company to fund his philanthropic efforts. Private equity firm MatlinPatterson (New York), which helped Huntsman avert bankruptcy in 2002 by agreeing to swap its Huntsman bond holdings for a big equity stake in the company, had also been looking to sell its stake, according to financial sources. The deal will likely face a lengthy antitrust review due to overlap in the epoxies businesses. Apollo appears determined to close the deal, betting $425 million that it can gain antitrust approvals. Apollo has agreed to pay Huntsman $325 million if the deal does not close due to the failure to obtain regulatory clearance or financing. It also agreed to pay half of the $200 million breakup fee to Basell. The process may be lengthy but Apollo appears confident that it can live with the conditions antitrust officials in Europe and the U.S. may impose.
Such deals contribute to the blurring of the distinction between “financial” and “strategic” buyers in the chemical industry. Some private equity firms are stepping beyond a simple “buy-and-flip” strategy, building scale, extending their geographic reach, and reducing cyclical risk by acquiring specialty and differentiated businesses. Such strategies previously were associated with industry buyers.

Basell to Buy Lyondell for $12 Billion

Basell has agreed to acquire Lyondell Chemical for $12.1 billion in an all cash transaction. Basell says it has offered Lyondell $48/share, a 20% premium to Lyondell’s July 16 closing price. The total value of the deal including debt is $19 billion, Basell says. Both companies say they have agreed to the deal. Lyondell is split into three businesses: ethylene, co-products, and derivatives; propylene oxide and related products; and refining. Those businesses will “complement and significantly strengthen Basell’s polyolefins business,” Basell says. Lyondell reported 2006 net income up 38%, to $735 million, on sales up 19%, to $22.2 billion. The combined company will have sales of about $34 billion. Access Industries, the parent company of Basell, expressed its interest in Lyondell in May 2007. Russian industrialist Leonard Blavatnik, who controls Access Industries, purchased the rights to buy an 8.3% stake in Lyondell in May. Lyondell is the latest company Basell has tried to buy. Basell offered to acquire General Electric’s GE Plastics business, but lost out to Sabic. Basell then offered to buy Huntsman, but was outbid by private equity firm Apollo Management earlier this month.

Wednesday, July 4, 2007

Apollo Trumps Basell with $10.4 Billion Huntsman Bid

Hexion Specialty Chemicals, owned by private equity firm Apollo Management, has launched a $10.4 billion, or $27.25/share, bid to acquire Huntsman, topping Basell’s previously announced $25.25/share agreement to acquire the company. Huntsman says that a committee of independent directors is evaluating the Hexion bid and “are engaged in discussions with Hexion regarding their proposal.” Basell is entitled to a $200 million payment if Huntsman accepts a higher bid, according to Huntsman. Hexion has agreed to fund $100 million of this payment, according to Huntsman. Hexion has leading positions in epoxy, phenolic, and formaldehyde-based resins as well as coatings and inks. There is overlap in the epoxies business. Hexion says it has a leading 34% global market share in epoxy resins. Huntsman currently ranks third in epoxies globally, and Hexion could be required to divest all or part of Huntsman’s epoxy business to gain antitrust approvals, analysts say. Dow Chemical is the other leading global epoxy producer, and the top-three producers account for about 75% of global capacity for epoxy resins, according to SRI Consulting (Menlo Park, CA). Hexion’s proposal includes a $325 million reverse break-up fee payable by Hexion to Huntsman “in the event the transaction does not close due to the failure to obtain regulatory clearance or requisite financing,” Huntsman says. The Huntsman family and investment firm MatlinPatterson together control a trust that owns 59% of Huntsman stock. MatlinPatterson owns about 55% of that trust, but the Huntsman family retains voting control of the trust, and, in effect, operating control of the company. Huntsman spurned offers from private equity buyers last year, including Apollo, that were in the low-$20/share range last year. Company founder and chairman Jon Huntsman told analysts at a Huntsman investor meeting earlier this year that the company was not for sale “unless I know I can get maximum dollar. I’m not going to give up what I’ve worked my entire life to build when someone comes in with an offer of $23-$24 /share.”